Skip to content

INFINITY™ EVERLAST™ 33681106Recalls & reported problems

Wright Medical Technology, Inc. · Class 2 · Implant

All models of INFINITY EVERLAST (20)

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
4
Deaths reported
0
Injuries reported
4
Recalls naming it
0

Summary

The FDA's MAUDE database contains 4 adverse event reports that list this exact device (DI 00889797074353), received between Dec 20, 2022 and Jan 23, 2025 — classified as 4 injuries.

The most frequently reported specific device problem is “Osseointegration Problem” (2 reports).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 1 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 1 reportsJan 2025: 1 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem3
  • Osseointegration Problem2

Patient problems

  • Implant Pain3
  • Inadequate Osseointegration2
  • Discomfort1
  • Fluid Discharge1
  • Joint Impingement1
  • Swelling/ Edema1
  • Unspecified Infection1

Recent adverse event reports

The 4 most recent of 4 reports, in the reporter's own words as published by the FDA.

  • InjuryJan 23, 2025Adverse Event Without Identified Device or Use Problem; Osseointegration Problem; Adverse Event Without Identified Device or Use Problem; Osseointegration Problem

    THE DIGITAL STRYKER PROPHECY TEAM RECEIVED A CT SCAN INDICATING THAT THE PATIENT MAY REQUIRE A REVISION SURGERY DUE TO PAIN AND IMPLANT SUBSIDENCE.

    Patient problems: Implant Pain; Inadequate Osseointegration

    MAUDE report 21215851 ↗
  • InjuryDec 30, 2024Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    AS REPORTED: "STUDY: STRYKER ITAR-2 SUBJECT: (B)(6)." DURING 2Y FOLLOW-UP VISIT ON (B)(6) 2024, SUBJECT REPORTED INCREASING PAIN AND SWELLING TO THE INSIDE ASPECT OF THE LEFT ANKLE. MUSCULOSKELETAL EXAM INDICATED DIFFUSE TENDERNESS TO THE MEDIAL REGION OF THE LEFT ANKLE AND SIGNIFICANT DISCOMFORT TO THE MEDIAL GUTTER. IMAGING RESULTS SHOWED A STABLE APPEARING LEFT TOTAL ANKLE REPLACEMENT WITH NO LUCENCY AROUND THE HARDWARE. POSSIBLE IMPINGEMENT OF THE MEDIAL GUTTER WAS NOTED. SUBJECT WILL CONTINUE TO FOLLOW-UP WITH SURGEON AND IF PAIN CONTINUES THE PATIENT COULD REQUIRE MEDIAL GUTTER DEBRIDEMENT OR POSSIBLY A SPECT CT SCAN. SUBJECT WAS PRESCRIBED MELOXICAM FOR PAIN.

    Patient problems: Discomfort; Implant Pain; Joint Impingement; Swelling/ Edema

    MAUDE report 21035636 ↗
  • InjuryAug 26, 2024Osseointegration Problem; Osseointegration Problem

    THE DIGITAL STRYKER PROPHECY TEAM RECEIVED A CT SCAN INDICATING THAT THE PATIENT UNDERWENT A DEVICE EXPLANT SURGERY DUE TO PATIENT HAVING PAIN AND POSSIBLE LOOSENING. THE PLAN IS TO EITHER FUSE OR REVISE WITH INVISION INBONE SYSTEM.

    Patient problems: Implant Pain; Inadequate Osseointegration

    MAUDE report 20071910 ↗
  • InjuryDec 20, 2022Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    IT WAS REPORTED THAT THE PATIENT AS JUST UNDER 2 WEEKS OUT FROM TOTAL ANKLE REPLACEMENT WITH MEDIAL MALL SCREW. THE PATIENT CAME IN FOR ROUTINE POSTOP VISIT ON (B)(6) 2022. IT WAS NOTED UPON WOUND INSPECTION THAT THERE WAS SOME DRAINAGE FROM THE MEDIAL WOUND. UPON PALPATION THERE WAS A FRANK PURULENCE. BECAUSE OF THIS, INDICATED FOR I&D. AN MRI SHOWED SOME POSSIBLE CONNECTION OF THE FLUID MEDIALLY ALONG WITH OUT OF THE ANTERIOR TIBIA ALONG THE SIDE OF THE IMPLANT. THE PATIENT HAS BEEN ON IV ANTIBIOTIC THERAPY WITH ROCEPHIN AND DAPTOMYCIN. THE PATIENT IS KEEPING THE FOOL ELEVATED, HAS BEEN NON-WEIGHT BEARING IN A SPLINT AND TAKING A BABY ASPIRIN TWICE DAILY FOR DVT PROPHYLAXIS. THE PAIN IS WELL CONTROLLED AND THE INFECTION IS IMPROVING.

    Patient problems: Fluid Discharge; Unspecified Infection

    MAUDE report 16019210 ↗

Other PROSTHESIS, ANKLE, SEMI-CONSTRAINED, CEMENTED, METAL/POLYMER devices

All PROSTHESIS, ANKLE, SEMI-CONSTRAINED, CEMENTED, METAL/POLYMER devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page